Home > Balance Sheet > MANKIND PHARMA

MANKIND PHARMA
Net Block

    Back to Balance Sheet
MANKIND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Net Block History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Net Block ₹18,620 Cr₹19,004 Cr₹4,540 Cr₹4,245 Cr₹3,583 Cr

What is the latest Net Block ratio of MANKIND PHARMA ?

The latest Net Block ratio of MANKIND PHARMA is ₹18,620 Cr based on Mar2026 Consolidated results.
Year Net Block
Mar2026₹18,620 Cr
Mar2025₹19,004 Cr
Mar2024₹4,540 Cr
Mar2023₹4,245 Cr
Mar2022₹3,583 Cr

How is Net Block of MANKIND PHARMA Trending?

Years Net Block % Change
Mar2026 ₹18,620 Cr
-2.02
Mar2025 ₹19,004 Cr
318.61
Mar2024 ₹4,540 Cr
6.94
Mar2023 ₹4,245 Cr
18.49
Mar2022 ₹3,583 Cr -

Compare Net Block of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹100,730.7 Cr -1.4% -3.7% -5.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹467,630.0 Cr -0.1% 0.5% 14% Stock Analytics
DIVIS LABORATORIES ₹218,972.0 Cr -0.9% 21.1% 25.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹188,358.0 Cr -1.3% 1.1% 32.7% Stock Analytics
CIPLA ₹118,916.0 Cr 0.2% 2.1% -5.1% Stock Analytics
DR REDDYS LABORATORIES ₹97,824.0 Cr 0.2% -7.7% -7.5% Stock Analytics


MANKIND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

-1.4%

-3.7%

-5.3%

SENSEX

0.5%

2.6%

-3.7%


You may also like the below Video Courses